Go to the list of all blogs
John Y White's Avatar
published in Blogs
Oct 06, 2026
Coupang (CPNG) and MercadoLibre (MELI): Diverging Fundamentals in Global E-Commerce

Coupang (CPNG) and MercadoLibre (MELI): Diverging Fundamentals in Global E-Commerce

Key Takeaways

  • CPNG has seen growth decelerate and profitability deteriorate in recent quarters, with a 52-week decline of more than 50% and a roughly 14% year-to-date pullback.
  • MELI is delivering revenue growth near 50% year over year, but compressed margins and heavy reinvestment have pressured its share price, which remains down roughly 14% over 52 weeks.
  • The two companies operate in distinct markets: Coupang is concentrated in South Korea with international expansion, while MercadoLibre is diversified across Latin America's largest economies.
  • MercadoLibre pairs e-commerce with a fast-growing fintech arm, whereas Coupang's broader "Developing Offerings" segment is still a drag on overall profitability.
  • Relative momentum and earnings quality currently appear more favorable for MELI, while CPNG faces near-term headwinds tied to fines, a data incident, and margin compression.

Setting the Context

Investors following global e-commerce often weigh CPNG against MELI, two sizable internet platforms with very different regional bases. Coupang leads in South Korean retail and is pushing into delivery, streaming, and fintech, while MercadoLibre anchors marketplace and payments activity across Latin America. A side-by-side look matters for growth and momentum investors who want to gauge performance, positioning, and risk. Both stocks have trailed the broader market over the past year, yet their underlying results have moved in sharply different directions.

Coupang's Recent Results

Coupang, Inc. (CPNG) operates primarily in South Korea through brands such as Coupang, Eats, Play, Rocket Now, and Farfetch. Its Product Commerce segment drives most revenue, while Developing Offerings covers food delivery, streaming, and international efforts. Performance has been difficult lately. The stock has dropped more than 50% over the trailing 52 weeks and is down roughly 14% year to date, lagging the S&P 500. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the momentum signals.

Several factors explain the pressure. Revenue growth has slowed, and the company posted a net loss in recent quarters. Management has pointed to the aftereffects of a 2025 data incident, regulatory fines, and continued losses from the Taiwan expansion. Product Commerce active customers have risen only modestly, and adjusted EBITDA in Developing Offerings stays negative. These issues have weighed on sentiment even though the company holds a large cash balance and a strong domestic position.

MercadoLibre's Recent Results

MercadoLibre, Inc. (MELI) runs an e-commerce and fintech platform across Brazil, Mexico, Argentina, and other markets via its marketplace and Mercado Pago payments system. Revenue has accelerated, climbing nearly 50% year over year in recent periods thanks to a lower free-shipping threshold in Brazil, rising credit-card use, and faster advertising growth. Gross merchandise volume and total payment volume have both posted double-digit gains.

Even with the strong top line, the stock has fallen roughly 14% over the trailing 52 weeks. Investors appear concerned about ongoing reinvestment, as operating margins have narrowed while spending rises on logistics, artificial intelligence, and credit expansion. Net income has declined year over year despite higher revenue. On the positive side, engagement metrics look solid, with unique buyers and fintech users both growing substantially and the credit portfolio expanding quickly while asset quality holds steady. I reviewed the relative performance using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Side-by-Side Comparison

The main differences show up in growth and geography. MELI is compounding revenue near 50% annually across a diversified, fast-growing region, while CPNG is expanding in the single digits and remains concentrated in one mature market. Profitability tells a more mixed story: MercadoLibre stays profitable but is accepting lower margins to support expansion, whereas Coupang has moved into losses amid fines, data-incident costs, and international spending.

Risk profiles also vary. Coupang carries specific concerns around the 2025 data breach and Taiwan losses, plus competitive pressure in Korea. MercadoLibre contends with macro and currency swings across Latin America plus credit exposure from its growing loan book. In positioning terms, MELI’s integrated commerce-plus-fintech model is further along, while CPNG’s Developing Offerings segment continues to pressure margins. These differences help explain why recent sentiment has leaned toward MELI even though both stocks have underperformed the broader market.

Assessment of Relative Strength

Based on factors such as trend consistency, revenue momentum, engagement growth, and diversification of catalysts, the balance currently favors MELI over CPNG. MercadoLibre’s near-50% revenue growth, expanding ecosystem, and improving cash generation create a stronger fundamental setting, even if margin compression adds volatility. Coupang’s slowing growth, ongoing losses, and company-specific issues point to a less stable near-term path. This view is probabilistic, and positioning could change with new earnings, margin trends, or market shifts.

Exploring Tickeron’s Trending AI Robots

Tickeron runs hundreds of AI Trading Bots that track and trade thousands of tickers, each with its own style, strategy, timeframe, risk profile, and performance stats. Market conditions shift quickly, so only a small number of bots fit the current environment at any time. I checked Tickeron’s Trending AI Robots page to review the top performers, which highlights projected profitability, trade frequency, win rates, and open positions so strategies can be compared quickly. Whether evaluating names like CPNG and MELI or scanning wider markets, the curated list helps identify algorithmic approaches aligned with current momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MELI, CPNG

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


MELI sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MELI moved above the 200-day moving average on September 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MELI's RSI Indicator exited the oversold zone, 18 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 62 cases where MELI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on MELI as a result. In 64 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

Following a +10.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where MELI advanced for three days, in 243 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

MELI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MELI turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 39 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

MELI moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MELI crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MELI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

The Aroon Indicator for MELI entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. MELI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.086) is normal, around the industry mean (56.916). P/E Ratio (46.584) is within average values for comparable stocks, (37.255). Projected Growth (PEG Ratio) (0.938) is also within normal values, averaging (1.774). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (2.651) is also within normal values, averaging (1.321).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MELI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Amazon.com (NASDAQ:AMZN), Alibaba Group Holding Limited (NYSE:BABA), PDD Holdings (NASDAQ:PDD), eBay (NASDAQ:EBAY), JD.com (NASDAQ:JD), Wayfair (NYSE:W), Chewy (NYSE:CHWY), Vipshop Holdings Limited (NYSE:VIPS), Revolve Group (NYSE:RVLV), Jumia Technologies AG (NYSE:JMIA).

Industry description

The internet retail industry includes companies that sell products and services through the Internet. With more and more consumers using online retailers, the companies have seen a big increase in the use of their services. Some of the companies in the group are focused on selling business-to-business products and services. Others sell business-to-consumer products and services. Internet retailers offer a wide variety of products like books, apparel, and electronics. Some companies even specialize in only one or two categories. One potentially critical factor for players to thrive in this space is the quality and speed of product delivery. This requires an investment in efficient distribution networks. Things like logistics are important factors in the success in the extremely competitive industry. For a company to stay relevant in the industry it must have effective pricing strategies and upgraded websites. The websites must be easy to navigate and engaging for customers. In addition to the revenues generated from straight sales, internet retailers can generate revenue from subscription fees and advertising. Amazon.com, Inc., Alibaba Group, and JD.com are some of the global leaders.

Market Cap

The average market capitalization across the Internet Retail Industry is 85.84B. The market cap for tickers in the group ranges from 585 to 2.66T. AMZN holds the highest valuation in this group at 2.66T. The lowest valued company is PIKM at 585.

High and low price notable news

The average weekly price growth across all stocks in the Internet Retail Industry was -1%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -15%. MI experienced the highest price growth at 195%, while NEXR experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Internet Retail Industry was 218%. For the same stocks of the Industry, the average monthly volume growth was 284% and the average quarterly volume growth was 58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 70
Price Growth Rating: 67
SMR Rating: 76
Profit Risk Rating: 94
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
MELI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a providesr of internet trading services

Industry InternetRetail

Industry
Internet Software Or Services
Address
WTC Free Zone
Phone
+598 29272770
Employees
123670
Web
https://www.mercadolibre.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.